Semaglutide 20mg
Semaglutide is a GLP-1 receptor agonist currently being researched for its interaction with appetite regulation, glucose metabolism, and metabolic signaling pathways. Research has focused on its potential role in supporting satiety signaling, gastric emptying, and energy balance mechanisms.
Studies have also explored Semaglutide’s relationship with body composition research, insulin-related signaling, and long-term metabolic regulation.
Common Research Uses
- Appetite regulation and satiety
- Metabolic and glucose signaling
- Gastric emptying and digestive response
- Body composition and weight management
Typical Research Dosing
Subcutaneous Protocol (20 mg + 3 mL BAC = ~6.67 mg/mL)
| Phase | Weekly Dose (mg) | Units per Injection |
|---|---|---|
| Weeks 1-4 | 0.25 mg once weekly | 4 units |
| Weeks 5-8 | 0.5 mg once weekly | 7.5 units |
| Weeks 9-12 | 1.0 mg once weekly | 15 units |
| Weeks 13-16 | 1.7 mg once weekly | 25.5 units |
| Weeks 17+ (Maintenance) | 2.4 mg once weekly | 36 units |
Based on reconstitution of 20 mg with 3 mL bacteriostatic water (~6.67 mg/mL).
Reconstitution Steps
- Prep clean: Wash hands, use a clean surface, and gather supplies.
- Sanitize: Alcohol swab vial stoppers and allow to air-dry.
- Add diluent slowly: Inject bacteriostatic water down the vial wall to reduce foaming.
- Mix gently: Gently swirl or roll until fully dissolved. Do not shake.
- Label: Write compound name, date, and concentration (mg/mL).
- Store appropriately: Store according to supplier guidance and maintain sterile technique.
Educational reference only
Injection Technique
General subcutaneous guidance from clinical best-practice resources.
- Allow the peptide to reach room temperature before injection.
- Clean the vial stopper and injection site with alcohol and allow to fully dry.
- Pinch a small skinfold and insert the needle at a 45–90° angle into subcutaneous tissue.
- Do not aspirate for subcutaneous injections; inject slowly and steadily.
- Rotate injection sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy.
- Inject slowly to help minimize any stinging sensation.
This information is provided for educational reference only and reflects general clinical best practices.
Recommended Source
We recommend MADDOG Peps for high-purity Semaglutide (20 mg).
- High-purity lots with manufacturer-issued third-party COAs available upon request for transparency and quality reference.
- Consistent handling practices aligned with quality control standards.
- Reliable fulfillment, careful packaging, and fast UPS shipping to help maintain product integrity.
How It Works
Semaglutide is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist designed to mimic the activity of the naturally occurring GLP-1 hormone involved in appetite and glucose regulation. Research suggests it works by activating GLP-1 receptors located throughout the pancreas, digestive system, and central nervous system.
Studies have explored Semaglutide’s potential role in increasing satiety signaling, slowing gastric emptying, and reducing overall caloric intake. Its interaction with appetite-regulating pathways in the brain has been a major area of metabolic and obesity-related research.
At the cellular and systemic level, Semaglutide has been studied for its influence on insulin signaling, glucagon regulation, and energy balance pathways associated with metabolic control. Researchers have also examined its potential effects on food reward signaling and long-term body composition changes. Unlike stimulant-based metabolic compounds, Semaglutide is being researched for its hormone-mimicking mechanism centered on appetite regulation and metabolic signaling rather than central nervous system stimulation.
Commonly Reported Side Effects
- Mild Headache
- Fatigue
- Vomiting
- Diarrhea
- Constipation
- Nausea
- Injection site reactions
These effects are based on commonly reported research observations and may vary by individual.